Nutrition and cognitive impairment in the elderly

被引:83
作者
González-Gross, M
Marcos, A
Pietrzik, K
机构
[1] Univ Complutense Madrid, Fac Farm, CSIC, Inst Nutr & Bromatol, E-28040 Madrid, Spain
[2] Univ Bonn, Inst Ernahrungswissensch, Abt Pathophysiol Ernahrung, D-53115 Bonn, Germany
关键词
dementia; vitamins; homocysteine; elderly; Alzheimer's disease;
D O I
10.1079/BJN2001388
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
As the number of older people is growing rapidly worldwide and the fact that elderly people are also apparently living longer, dementia, the most common cause of cognitive impairment is getting to be a greater public health problem. Nutrition plays a role in the ageing process, but there is still a lack of knowledge about nutrition-related risk factors in cognitive impairment. Research in this area has been intensive during the last decade, and results indicate that subclinical deficiency in essential nutrients (antioxidants such as vitamins C, E and beta -carotene, vitamin B-12, vitamin B-6, folate) and nutrition-related disorders, as hypercholesterolaemia, hypertriacylglycerolaemia, hypertension, and diabetes could be some of the nutrition-related risk factors, which can be present for a long time before cognitive impairment becomes evident. Large-scale clinical trials in high-risk populations are needed to determine whether lowering blood homocysteine levels reduces the risk of cognitive impairment and may delay the clinical onset of dementia and perhaps of Alzheimer's disease. A curative treatment of cognitive impairment, especially Alzheimer's disease, is currently impossible. Actual drug therapy, if started early enough, may slow down the progression of the disease. Longitudinal studies are required in order to establish the possible link of nutrient intake - nutritional status with cognitive impairment, and if it is possible, in fact, to inhibit or delay the onset of dementia.
引用
收藏
页码:313 / 321
页数:9
相关论文
共 104 条
[1]  
Agronin ME, 1998, GERIATRICS-US, V53, pS35
[2]  
Araki A., 1999, Amino Acids (Vienna), V17, P44
[3]   COBALAMIN LEVELS ARE NOT REDUCED IN ALZHEIMERS-DISEASE - RESULTS FROM A POPULATION-BASED STUDY [J].
BASUN, H ;
FRATIGLIONI, L ;
WINBLAD, B .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1994, 42 (02) :132-136
[4]   Vitamin E and other antioxidants in neuroprotection [J].
Behl, C .
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 1999, 69 (03) :213-219
[5]   Oxidative stress during the pathogenesis of Alzheimer's disease and antioxidant neuroprotection [J].
Behl, C ;
Holsboer, F .
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 1998, 66 (03) :113-121
[6]   PLASMA HOMOCYSTEINE IN VASCULAR-DISEASE AND IN NONVASCULAR DEMENTIA OF DEPRESSED ELDERLY PEOPLE [J].
BELL, IR ;
EDMAN, JS ;
SELHUB, J ;
MORROW, FD ;
MARBY, DW ;
KAYNE, HL ;
COLE, JO .
ACTA PSYCHIATRICA SCANDINAVICA, 1992, 86 (05) :386-390
[7]  
Birge SJ, 1998, GERIATRICS, V53, pS28
[8]  
Birkhäuser MH, 2000, INT J GERIATR PSYCH, V15, P600
[9]   Relationships between cholesterol, apolipoprotein E polymorphism and dementia: A cross-sectional analysis from the PAQUID study [J].
Bonarek, M ;
Barberger-Gateau, P ;
Letenneur, L ;
Deschamps, V ;
Iron, A ;
Dubroca, B ;
Dartigues, JF .
NEUROEPIDEMIOLOGY, 2000, 19 (03) :141-148
[10]   FOLATE-RESPONSIVE NEUROLOGICAL AND MENTAL-DISORDERS - REPORT OF 16 CASES - NEUROPSYCHOLOGICAL CORRELATES OF COMPUTERIZED TRANSAXIAL TOMOGRAPHY AND RADIONUCLIDE CISTERNOGRAPHY IN FOLIC-ACID DEFICIENCIES [J].
BOTEZ, MI ;
FONTAINE, F ;
BOTEZ, T ;
BACHEVALIER, J .
EUROPEAN NEUROLOGY, 1977, 16 (1-6) :230-246